Update on the Pathology of Dystonia

по Standaert, David G.
Опубликовано 2011

Dysregulation of BET Proteins in Levodopa-Induced Dyskinesia

по Figge, David, Standaert, David G.
Опубликовано в: Neurobiol Dis (2017)

Dystonia and levodopa-induced dyskinesias in Parkinson disease: Is there a connection?

по Calabresi, Paolo, Standaert, David G.
Опубликовано в: Neurobiol Dis (2019)

Targets for Neuroprotection in Parkinson’s Disease

по Yacoubian, Talene A., Standaert, David G.
Опубликовано 2008

Parkinson Disease, Primates, and Gene Therapy: Vive la Différence?

по Lewis, Travis B., Standaert, David G.
Опубликовано 2010

Metabolomics and the Search for Parkinson Biomarkers

по Amara, Amy W., Standaert, David G.
Опубликовано 2013

Dopamine D1 Receptor-Dependent Trafficking of Striatal NMDA Glutamate Receptors to the Postsynaptic Membrane

по Dunah, Anthone W., Standaert, David G.
Опубликовано в: J Neurosci (2001)

Brain Alchemy: Transforming Astrocytes into Neurons for Neurodegenerative Disease

по Williams, Gregory P., Standaert, David G.
Опубликовано в: Mov Disord Clin Pract (2020)

Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease

по Cao, Shuwen, Theodore, Shaji, Standaert, David G
Опубликовано 2010

The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia

по Cao, Shuwen, Standaert, David G, Harms, Ashley S
Опубликовано 2012

Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease

по Allen Reish, Heather E., Standaert, David G.
Опубликовано в: J Parkinsons Dis (2015)

Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease

по Thome, Aaron D., Standaert, David G., Harms, Ashley S.
Опубликовано в: PLoS One (2015)

A neuroprotective role for angiogenin in models of Parkinson’s Disease

по Steidinger, Trent U., Standaert, David G., Yacoubian, Talene A.
Опубликовано 2010

Dynamic DNA Methylation Regulates Levodopa-Induced Dyskinesia

по Figge, David A., Eskow Jaunarajs, Karen L., Standaert, David G.
Опубликовано в: J Neurosci (2016)

Angiotensin II protects against α-synuclein toxicity and reduces protein aggregation in vitro

по Grammatopoulos, Tom N., Outeiro, Tiago F., Hyman, Bradley T., Standaert, David G.
Опубликовано 2007

Targeted Overexpression of Human Alpha-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease

по Theodore, Shaji, Cao, Shuwen, McLean, Pamela J., Standaert, David G.
Опубликовано 2008

Alteration of Striatal Dopaminergic Neurotransmission in a Mouse Model of DYT11 Myoclonus-Dystonia

по Zhang, Lin, Yokoi, Fumiaki, Parsons, Dee S., Standaert, David G., Li, Yuqing
Опубликовано 2012

Evaluation of TorsinA as a Target for Parkinson Disease Therapy in Mouse Models

по Li, Xinru, Lee, Jenny, Parsons, Dee, Janaurajs, Karen, Standaert, David G.
Опубликовано 2012

Reply to letter: Suicide in Parkinson's disease patients treated with levodopa‐carbidopa Intestinal Gel

по Fernandez, Hubert H., Standaert, David G., Chatamra, Krai, Benesh, Janet A.
Опубликовано в: Mov Disord (2015)

Motor Deficits and Decreased Striatal Dopamine Receptor 2 Binding Activity in the Striatum-Specific Dyt1 Conditional Knockout Mice

по Yokoi, Fumiaki, Dang, Mai Tu, Li, Jianyong, Standaert, David G., Li, Yuqing
Опубликовано 2011